AzTrials
AzTrials

Acute StrokeCANVASNCT02677415

Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment

A study testing Intravenous anesthetics, local anesthesia and Spontaneous breathing in people with Acute Stroke, run by Beijing Tiantan Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Recent observational studies have found an association between general anaesthesia and increased post-operative mortality in acute ischemic stroke patients undergoing endovascular treatment. It is unknown whether there is a causal relationship in this observation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Stroke
What is being tested?
Intravenous anesthetics, local anesthesia and Spontaneous breathing
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
640 participants
Where
1 siteChina
Study dates
Sep 2016to Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with AIS scheduled to receive emergency endovascular treatment, older than 18; the onset time is within 12 hours.

Who cannot join

  • Radiological ambiguity concerning infarction and vessel occlusion.
  • Additional intracerebral hemorrhage.
  • Posterior circulation infraction.
  • Coma on admission (Glasgow coma score less than 8).
  • NIHSS less than 10 or more than 35.
  • Severe agitation or seizures on admission.
Show all 9Show fewer
  • Obvious loss of airway protective reflexes and/or vomiting on admission.
  • Being intubated before treatment on admission.
  • Known allergy to anesthetic or analgesic.

Trial locations and contacts

1 site in 1 country.

Ruquan Han, M.D., Ph.D. contact

8610-67096660

ruquan.han@gmail.com

China1 site, 1 recruiting
  • Beijing TianTan Hospital

    Beijing, 100050

    Ruquan Han, M.D., Ph.D, 8610-67096660, ruquan.han@gmail.com

    Recruiting

Other trials in China

About this study

Official title: Impact of General vs Local Anesthesia on Neurological Function in Patients With Acute Ischemic Stroke Undergoing Endovascular Treatment

Recent observational studies have found an association between general anaesthesia and increased post-operative mortality in acute ischemic stroke patients undergoing endovascular treatment. It is unknown whether there is a causal relationship in this observation. The investigators are performing a large randomised trial of general versus local anaesthesia to definitively answer the question of whether anaesthetic type alters perioperative outcome.

Conditions
Acute Stroke
Being tested
Intravenous anesthetics, local anesthesia, Controlled ventilation, Spontaneous breathing
Keywords
Ischemic Stroke, Anesthesia, Endovascular Procedures
Medical subject headings
Stroke, Ischemic Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intravenous anestheticsOther

  • local anesthesiaOther

  • Controlled ventilationOther

  • Spontaneous breathingOther

Study groups in NCT02677415
Study groupRoleWhat they receive
Local anesthesiaOtherlocal anesthesia and spontaneous breathing will be maintained.
Receives: Other: local anesthesia; Other: Spontaneous breathing
General anesthesiaOtherIntravenous anesthetics and controlled ventilation will be used .
Receives: Other: Intravenous anesthetics; Other: Controlled ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. modified Rankin score

    Measured: post-procedural 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionDec 2022 (estimated)
  4. Study completionDec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
640 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02677415
Sponsor's protocol ID
QML20150508
Acronym
CANVAS
Status last verified
Sep 2021
First submitted
5 Feb 2016
Last updated
14 Sep 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Tosello R, Riera R, Tosello G, Clezar CN, Amorim JE, Vasconcelos V, Joao BB, Flumignan RL. Type of anaesthesia for acute ischaemic stroke endovascular treatment. Cochrane Database Syst Rev. 2022 Jul 20;7(7):CD013690. doi: 10.1002/14651858.CD013690.pub2.

    PubMed 35857365
  • Peng Y, Li Y, Jian M, Liu X, Sun J, Jia B, Dong J, Zeng M, Lin N, Zhang L, Gelb AW, Chan MT, Han R. Choice of ANesthesia for EndoVAScular Treatment of Acute Ischemic Stroke: Protocol for a randomized controlled (CANVAS) trial. Int J Stroke. 2017 Dec;12(9):991-997. doi: 10.1177/1747493017706243. Epub 2017 Apr 24.

    PubMed 28436307

Questions about this trial

What is this clinical trial studying?

A study testing Intravenous anesthetics, local anesthesia and Spontaneous breathing in people with Acute Stroke, run by Beijing Tiantan Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ruquan Han, M.D., Ph.D. (8610-67096660, ruquan.han@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

modified Rankin score (time frame: post-procedural 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02677415, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in